Jul 26, 2019 / 11:30AM GMT
Operator
Good day, ladies and gentlemen, and a very warm welcome to the Jubilant Life Sciences Q1 FY '20 Earnings Conference Call. (Operator Instructions)
Please note that this conference is being recorded.
I now hand the conference over to Mr. Ravi Agrawal, Head of Investor Relations at Jubilant Life Sciences Limited. Thank you, and over to you, sir.
Ravi Agrawal - Jubilant Life Sciences Limited - Head of IR
Good evening, everybody. I'm Ravi Agrawal, Head of Investor Relations at Jubilant Life Sciences. I thank you again for being with us today on our Q1 FY '20 earnings conference call.
I would like to remind you that some of the statements made on the call today could be forward looking in nature, and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.
On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari S. Bhartia, Co-Chairman and Managing Director; Mr. R. Sankaraiah, Executive Director of Finance; Mr. Pramod Yadav, CEO, Jubilant Pharma; Mr. Rajesh
Q1 2020 Jubilant Life Sciences Ltd Earnings Call Transcript
Jul 26, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers